5.68
전일 마감가:
$5.56
열려 있는:
$5.56
하루 거래량:
966.71K
Relative Volume:
0.67
시가총액:
$790.23M
수익:
$62.04M
순이익/손실:
$-533.34M
주가수익비율:
-1.449
EPS:
-3.92
순현금흐름:
$-473.07M
1주 성능:
+0.89%
1개월 성능:
-9.41%
6개월 성능:
+25.94%
1년 성능:
-18.27%
비르 바이오테크 Stock (VIR) Company Profile
명칭
Vir Biotechnology Inc
전화
415-906-4324
주소
1800 OWENS STREET, SAN FRANCISCO, CA
VIR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
VIR
Vir Biotechnology Inc
|
5.68 | 773.54M | 62.04M | -533.34M | -473.07M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
비르 바이오테크 Stock (VIR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 개시 | Evercore ISI | Outperform |
| 2025-08-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-01-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-03-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-02-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-01-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | 개시 | SVB Leerink | Outperform |
| 2022-09-09 | 개시 | Morgan Stanley | Underweight |
| 2022-03-03 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2021-12-21 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2021-10-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-06-04 | 재개 | Robert W. Baird | Neutral |
| 2021-01-27 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-05 | 개시 | BofA Securities | Buy |
| 2020-09-14 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-11 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-08-20 | 개시 | Needham | Buy |
| 2020-03-19 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-03-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-02-27 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-02-04 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-11-14 | 개시 | Robert W. Baird | Neutral |
| 2019-11-05 | 개시 | Barclays | Overweight |
| 2019-11-05 | 개시 | Cowen | Outperform |
| 2019-11-05 | 개시 | Goldman | Buy |
| 2019-11-05 | 개시 | JP Morgan | Overweight |
모두보기
비르 바이오테크 주식(VIR)의 최신 뉴스
H.C. Wainwright Keeps Their Buy Rating on Vir Biotechnology (VIR) - The Globe and Mail
How to manage a losing position in Vir Biotechnology Inc.Weekly Stock Report & AI Enhanced Trade Execution Alerts - newser.com
Is Vir Biotechnology Inc. stock gaining market shareRisk Management & Long Hold Capital Preservation Tips - newser.com
Vir Biotechnology to Participate in the 8th Annual Evercore Healthcare Conference - BioSpace
How Vir Biotechnology Inc. stock reacts to job market dataWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
What margin trends mean for Vir Biotechnology Inc. stockMarket Trend Summary & Entry Point Confirmation Alerts - newser.com
Vir Biotechnology (NASDAQ:VIR) CFO Sells $37,802.44 in Stock - MarketBeat
Will Vir Biotechnology Inc. stock deliver consistent dividendsTrade Volume Summary & High Win Rate Trade Alerts - newser.com
Why Vir Biotechnology Inc. stock is favored by top institutionsJuly 2025 Momentum & Reliable Intraday Trade Alerts - newser.com
What to do if you’re stuck in Vir Biotechnology Inc.Market Trend Summary & Daily Stock Trend Reports - newser.com
How Vir Biotechnology Inc. stock reacts to oil pricesWeekly Volume Report & Target Return Focused Picks - newser.com
Vir Biotechnology EVP O’Byrne sells $37,782 in shares By Investing.com - Investing.com Australia
Vir Biotechnology EVP O’Byrne sells $37,782 in shares - Investing.com
[Form 4] Vir Biotechnology, Inc. Insider Trading Activity - Stock Titan
Vir Biotechnology EVP & CFO Jason O'Byrne Sells Shares - TradingView
CFO O'Byrne Surrenders 6,799 Of Vir Biotechnology Inc [VIR] - TradingView
Vir Biotechnology at Jefferies Conference: Advancing in Oncology and Infectious Diseases - Investing.com Canada
Risk adjusted return profile for Vir Biotechnology Inc. analyzedChart Signals & Verified Technical Signals - newser.com
Vir Biotechnology Stock Set For Premarket Surge? Retail Trader Hopes Swell As ‘Phenomenal’ HDV Data Sets Stage For Gilead Showdown - MSN
CFO O'Byrne Files To Sell 6,799 Of Vir Biotechnology Inc [VIR] - TradingView
Is Vir Biotechnology Inc. forming a reversal patternPortfolio Update Report & Proven Capital Preservation Methods - newser.com
Is it too late to sell Vir Biotechnology Inc.2025 Trading Volume Trends & Daily Chart Pattern Signal Reports - newser.com
What analysts say about Vir Biotechnology Inc stockSupport Zone Identification & Rapid Portfolio Trading - earlytimes.in
Vir Biotechnology Inc. stock trendline breakdown2025 Earnings Impact & Reliable Trade Execution Plans - newser.com
Can technical indicators confirm Vir Biotechnology Inc.’s reversalRisk Management & Free Community Consensus Stock Picks - newser.com
Visualizing Vir Biotechnology Inc. stock with heatmapsJuly 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com
How to escape a deep drawdown in Vir Biotechnology Inc.Market Sentiment Review & Risk Controlled Daily Trade Plans - newser.com
What the charts say about Vir Biotechnology Inc. todayWeekly Profit Analysis & Community Verified Watchlist Alerts - newser.com
Best data tools to analyze Vir Biotechnology Inc. stock2025 Market Trends & Verified Trade Idea Suggestions - newser.com
Published on: 2025-11-13 12:49:36 - newser.com
Tools to monitor Vir Biotechnology Inc. recovery probabilityTrade Volume Report & Real-Time Buy Signal Alerts - newser.com
Vir Biotechnology, Inc. (VIR) Stock Forecasts - Yahoo Finance
비르 바이오테크 (VIR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):